Related Experiment Video
Updated: May 17, 2026

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
Novel approaches to epilepsy treatment
Andreas T Sørensen1, Merab Kokaia
1Experimental Epilepsy Group, Division of Neurology, Lund University Hospital, Lund, Sweden.
Novel stem-cell and gene therapies show promise for treating drug-resistant epilepsy. These approaches target specific pathways and offer hope for patients with refractory epilepsy.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Molecular Genetics
Background:
- Epilepsy treatment faces challenges with drug resistance and side effects from antiepileptic drugs (AEDs), impacting 30-40% of patients.
- Complete seizure freedom remains an unmet need in current epilepsy management.
- Novel therapeutic strategies are crucial for addressing refractory epilepsy.
Purpose of the Study:
- To review recent advancements in stem-cell-based and gene transfer-based therapies for epilepsy.
- To discuss the potential clinical applications of these novel approaches.
- To highlight therapeutic targets and molecular-genetic strategies for epilepsy treatment.
Main Methods:
- Review of findings from animal models of epilepsy.
- Analysis of stem-cell-based therapeutic strategies.
- Evaluation of gene transfer-based therapeutic approaches, including optogenetics.
- Identification of therapeutic targets such as neuropeptides, neurotrophic factors, and inhibitory neurotransmitters.
Main Results:
- Stem-cell and gene therapies demonstrate proof-of-principle in preclinical epilepsy models.
- These novel strategies offer potential for targeting specific molecular pathways involved in seizures.
- Optogenetic technology presents a new avenue for molecular-genetic epilepsy treatment.
Conclusions:
- Stem-cell and gene therapies represent promising avenues for treating refractory epilepsy.
- These approaches may offer more targeted and effective treatments compared to conventional antiepileptic drugs.
- Further research and clinical translation are needed to realize the full potential of these innovative therapies for epilepsy.
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Electroconvulsive Therapy
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...

